Journal article
10-year performance of four models of breast cancer risk: a validation study
MB Terry, Y Liao, AS Whittemore, N Leoce, R Buchsbaum, N Zeinomar, GS Dite, WK Chung, JA Knight, MC Southey, RL Milne, D Goldgar, GG Giles, SA McLachlan, ML Friedlander, PC Weideman, G Glendon, S Nesci, IL Andrulis, EM John Show all
Lancet Oncology | ELSEVIER SCIENCE INC | Published : 2019
Abstract
Background: Independent validation is essential to justify use of models of breast cancer risk prediction and inform decisions about prevention options and screening. Few independent validations had been done using cohorts for common breast cancer risk prediction models, and those that have been done had small sample sizes and short follow-up periods, and used earlier versions of the prediction tools. We aimed to validate the relative performance of four commonly used models of breast cancer risk and assess the effect of limited data input on each one's performance. Methods: In this validation study, we used the Breast Cancer Prospective Family Study Cohort (ProF-SC), which includes 18 856 w..
View full abstractRelated Projects (4)
Grants
Awarded by National Institutes of Health
Funding Acknowledgements
US National Institutes of Health, National Cancer Institute, Breast Cancer Research Foundation, Australian National Health and Medical Research Council, Victorian Health Promotion Foundation, Victorian Breast Cancer Research Consortium, Cancer Australia, National Breast Cancer Foundation, Queensland Cancer Fund, Cancer Councils of New South Wales, Victoria, Tasmania, and South Australia, and Cancer Foundation of Western Australia.